Axillary Hyperpigmentation. Other melanin hyperpigmentation
Conditions
Interventions
Intervention 1: Intervention group: Dynamis LASER + Hydroquinone 2% once in Razi LASER clinic. Intervention 2: Control group: Hydroquinone 2% made in compounding pharmacy department of raze skin hospi
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: The skin of the axilla is at least two shades darker than the surrounding normal axillary skin
Exclusion criteria
Exclusion criteria: Participants with systemic diseases, skin conditions affecting the axilla, acanthosis nigricans, or dermatologic disorders associated with abnormal hyperpigmentation (such as Riehl's melanosis or lichen planus pigmentosus) Participants receiving heavy metals (e.g., silver), chemotherapy, or antiretroviral medications that may cause increased pigmentation Pregnant or breastfeeding participants Participants undergoing ongoing treatment with topical lightening agents (such as vitamin C, hydroquinone, or retinoids) within two weeks prior to the study Participants who had received laser therapy or other dermatologic treatments in the axillary area within eight weeks prior to the study. Participants who experienced shoulder pain or stiffness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Axillary Hyperpigmentation improvement. Timepoint: aFTER TREATMENT AND 3 MONTH LATER. Method of measurement: Investigator evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfshin Fahimi
Tehran University of Medical Sciences
Outcome results
None listed